Thailand Analgesics Market Report: Trends, Growth and Forecast (2026-2032)
By Product (Systemic Analgesics (Adult Analgesics, Paediatric Analgesics, Combined Systemic Analgesics), Topical Analgesics/Anaesthetic), By Drug Type (Opioid Analgesics (Strong Opioids, Weak Opioids), Non-opioid Analgesics (Acetaminophen, Aspirin, Combination Products, Diclofenac, Dipyrone, Ibuprofen, Ketoprofen, Naproxen, OTC Triptans), Compound/Combination Analgesics (Opioid + Non-Opioid Combinations, Multi-Ingredient Non-Opioid Combinations)), By Route of Administration (Oral, Parenteral/Injectable, Topical/External, Transdermal, Rectal/Other), By Pain Type (Acute Pain, Chronic Pain, Breakthrough Pain), By Application (Surgical & Post-operative Pain, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Migraine/Headache, Dental Pain, Others), By Sales Channel (Retail Offline (Offline Pharmacies, Hospital Pharmacies), Retail Online (Online Pharmacies)), By Prescription Type (Prescription, OTC), By Formulation (Tablets, Capsules, Liquids, Injectables, Gels/Creams, Patches), By End User (Hospitals, Clinics/ASCs, Homecare)
|
Major Players
|
Thailand Analgesics Market Statistics and Insights, 2026
- Market Size Statistics
- Analgesics market size in Thailand was valued at USD 340 million in 2025 and is estimated at USD 365 million in 2026.
- The market size is expected to grow to USD 420 million by 2032.
- Market to register a CAGR of around 3.06% during 2026-32.
- Product Shares
- Systemic analgesics grabbed market share of 55%.
- Competition
- More than 20 companies are actively engaged in producing analgesics in Thailand.
- Top 5 companies acquired around 35% of the market share.
- Golden Cup Pharmaceutical Co Ltd, Pfizer (Thailand) Co Ltd, Government Pharmaceutical Organization The, Thai Nakorn Patana Co Ltd, Taisho Pharmaceutical Co Ltd etc., are few of the top companies.
- Sales Channel
- Retail offline grabbed 60% of the market.
Thailand Analgesics Market Outlook
Thailand analgesics market size was valued at USD 340 million in 2025 and is projected to grow from USD 365 million in 2026 to USD 420 million by 2032, exhibiting a CAGR of 3.06% during the forecast period. Growth remains supported by rising demand across both adult and paediatric pain relief, with stronger consumer reliance on self medication and steady need for practical products that can address everyday pain, fever, and muscle discomfort.
Demand continues to benefit from Thailand’s ageing population, which keeps the need for regular pain management visible across daily life. Older consumers often require pain relief for joint pain, muscle complaints, and inflammation, while active lifestyles also support wider use of products for muscle strain and exercise related discomfort. Alongside this, inbound tourism adds another layer of demand, especially for topical and herbal options that are popular for personal use and souvenir purchases.
By product, systemic analgesics hold the leading share at around 55%, supported by their broad use for headaches, fever, muscle pain, toothache, and other common conditions that consumers want to manage quickly. At the same time, the category continues to see interest in herbal and topical alternatives, especially among buyers who prefer non systemic options or want products targeted at a specific area of pain rather than general oral relief.
By sales channel, retail offline leads with around 60% share, as physical pharmacies and drugstores remain the preferred purchase points for immediate and trusted pain relief. Analgesics continue to benefit from strong pharmacy access because consumers often want fast advice and instant use rather than waiting for delivery. Although online channels are growing, store based buying remains central due to trust, convenience, and the structured role of pharmacies in minor symptom care across the category.

Thailand Analgesics Market Growth DriverAgeing Population Supports Routine Pain Relief Demand
A rapidly ageing population continues to support analgesics demand in Thailand. Older consumers are more likely to face joint pain, back pain, and other recurring discomforts, which keeps everyday pain relief relevant in regular self care. This also supports continued use of familiar products that offer quick and practical relief for common pain conditions.
An official Thailand presentation delivered to United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP) by the Department of Older Persons in June 2025 states that the country has 13.45 million older persons, equal to 20.38% of the population. This large older consumer base keeps pain management needs visible and supports steady demand for analgesic products across daily healthcare use.
Thailand Analgesics Market ChallengeOnline Safety Concerns Restrain Faster Channel Shift
Consumer safety risks in online buying create a challenge for analgesics in Thailand. While digital channels are expanding, shoppers remain cautious when health products are involved because product quality, seller identity, and platform reliability matter more in medicine related purchases. This limits faster movement away from trusted store based buying.
Electronic Transactions Development Agency reports that Thailand records 39,112 online complaints in 2025, up 10.62% from 2024, with 14,238 cases or 36.40% linked to online buying. Electronic Transactions Development Agency (ETDA) also says 19 high risk online marketplace services come under added duties from 10 July 2025, including seller verification, product checks, and complaint handling. These conditions show why trust remains a key barrier in online medicine purchases.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Thailand Analgesics Market TrendPharmacy-Led Self-Care Becomes More Visible
A clearer trend in Thailand is the stronger role of pharmacy led self care for minor symptoms. Consumers increasingly use nearby pharmacies for fast advice and immediate access to medicines, which supports wider use of analgesics for common issues such as headache, muscle pain, toothache, menstrual pain, and fever.
Thailand’s National Health Security Office (NHSO) says the nationwide “30 baht healthcare anywhere” policy was officially launched in August 2025, and its quality pharmacies now support care for 32 minor symptom groups. The listed conditions include headache, joint or muscle pain, toothache, menstrual pain, and fever. This stronger pharmacy role supports easier and more structured self medication in the country.
Thailand Analgesics Market OpportunityTourism Creates Room for Topical and Herbal Products
Inbound tourism creates a clear opportunity for analgesics in Thailand, especially for topical and herbal pain relief products. Tourists often look for convenient remedies for muscle aches, strains, and travel related discomfort, while well known local formats such as balms and oils also attract demand as personal use and souvenir purchases.
Official tourism indicators from the Bank of Thailand, using Ministry of Tourism and Sports data, show 3.37 million foreign tourists visit Thailand in December 2025, followed by 3.28 million in January 2026 and 3.26 million in February 2026. Total accommodation occupancy also stays high at 78.05% in December 2025. This sustained visitor flow supports added sales potential for travel friendly analgesic products.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Thailand Analgesics Market Segmentation Analysis
By Product
- Systemic Analgesics
- Adult Analgesics
- Paediatric Analgesics
- Combined Systemic Analgesics
- Topical Analgesics/Anaesthetic
The segment with the highest share under the product is systemic analgesics, holding around 55% of the Thailand analgesics market in value terms. This segment stays ahead because oral pain relief products remain widely used for headaches, fever, muscle pain, joint discomfort, and other common conditions that consumers want to manage quickly and simply.
Its leading position is supported by Thailand’s ageing profile and broad pain management need. An official June 2025 presentation by the Department of Older Persons states that Thailand has 13.45 million older persons, equal to 20.38% of the population. This larger older group supports regular use of systemic analgesics for recurring aches and pains in everyday life.

By Sales Channel
- Retail Offline
- Offline Pharmacies
- Hospital Pharmacies
- Retail Online
- Online Pharmacies
The segment with the highest share under the sales channel is retail offline, accounting for around 60% of the Thailand analgesics market in value terms. This channel leads because consumers still prefer physical pharmacies and drugstores for quick access, trusted advice, and immediate purchase of pain relief products, especially when medicines are needed without delay.
Retail offline stays ahead because Thailand’s healthcare access remains closely linked with pharmacy support. The NHSO says quality pharmacies now cover 32 minor symptom groups under the national 30 baht healthcare anywhere policy, while the Thai Food and Drug Administration (FDA) says its health product vigilance system operates through a network of more than 1,000 public and private healthcare facilities, including pharmacies. This keeps store based medicine buying more trusted and practical.
List of Companies Covered in Thailand Analgesics Market
The companies listed below are highly influential in the Thailand analgesics market, with a significant market share and a strong impact on industry developments.
- Golden Cup Pharmaceutical Co Ltd
- Pfizer (Thailand) Co Ltd
- Government Pharmaceutical Organization The
- Thai Nakorn Patana Co Ltd
- Taisho Pharmaceutical Co Ltd
- GSK Consumer Healthcare
- Johnson & Johnson (Thailand) Ltd
- Haw Par Tiger Balm (Thailand) Ltd
- Bertram Chemical (1982) Co Ltd
- Bristol-Myers Squibb (Thailand) Ltd
Competitive Landscape
In 2025, analgesics in Thailand recorded rising demand across both adult and paediatric segments, supported by domestic consumption and increased purchases from inbound tourists, particularly for herbal and traditional topical products such as balms and oils. Thai Nakorn Patana Co Ltd led the market with a 10.6% value share, followed by Taisho Pharmaceutical Co Ltd at 8.4%, within a fragmented competitive landscape. Strong demand was seen for acetaminophen, combination products, and topical analgesics, with herbal options gaining traction due to consumer preference for natural ingredients. Growth was further driven by an ageing population, active lifestyles, and rising self-medication, while pharmacies remained the dominant distribution channel due to accessibility and consumer trust. However, increasing interest in vitamins, supplements, and alternative remedies introduced some constraints, as consumers explored preventative health approaches alongside conventional pain relief solutions.
Frequently Asked Questions
Related Report
- Market Segmentation
- Research Scope
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Thailand Analgesics Market Policies, Regulations, and Standards
- Thailand Analgesics Market Dynamics
- Growth Factors
- Challenges
- Trends
- Opportunities
- Thailand Analgesics Market Statistics, 2022-2032F
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Product
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Adult Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Combined Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Topical Analgesics/Anaesthetic- Market Insights and Forecast 2022-2032, USD Million
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Drug Type
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Strong Opioids- Market Insights and Forecast 2022-2032, USD Million
- Weak Opioids- Market Insights and Forecast 2022-2032, USD Million
- Non-opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Acetaminophen- Market Insights and Forecast 2022-2032, USD Million
- Aspirin- Market Insights and Forecast 2022-2032, USD Million
- Combination Products- Market Insights and Forecast 2022-2032, USD Million
- Diclofenac- Market Insights and Forecast 2022-2032, USD Million
- Dipyrone- Market Insights and Forecast 2022-2032, USD Million
- Ibuprofen- Market Insights and Forecast 2022-2032, USD Million
- Ketoprofen- Market Insights and Forecast 2022-2032, USD Million
- Naproxen- Market Insights and Forecast 2022-2032, USD Million
- OTC Triptans- Market Insights and Forecast 2022-2032, USD Million
- Compound/Combination Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Opioid + Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Multi-Ingredient Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration
- Oral- Market Insights and Forecast 2022-2032, USD Million
- Parenteral/Injectable- Market Insights and Forecast 2022-2032, USD Million
- Topical/External- Market Insights and Forecast 2022-2032, USD Million
- Transdermal- Market Insights and Forecast 2022-2032, USD Million
- Rectal/Other- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type
- Acute Pain- Market Insights and Forecast 2022-2032, USD Million
- Chronic Pain- Market Insights and Forecast 2022-2032, USD Million
- Breakthrough Pain- Market Insights and Forecast 2022-2032, USD Million
- By Application
- Surgical & Post-operative Pain- Market Insights and Forecast 2022-2032, USD Million
- Musculoskeletal Pain- Market Insights and Forecast 2022-2032, USD Million
- Neuropathic Pain- Market Insights and Forecast 2022-2032, USD Million
- Cancer Pain- Market Insights and Forecast 2022-2032, USD Million
- Migraine/Headache- Market Insights and Forecast 2022-2032, USD Million
- Dental Pain- Market Insights and Forecast 2022-2032, USD Million
- Others- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- Offline Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Hospital Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type
- Prescription- Market Insights and Forecast 2022-2032, USD Million
- OTC- Market Insights and Forecast 2022-2032, USD Million
- By Formulation
- Tablets- Market Insights and Forecast 2022-2032, USD Million
- Capsules- Market Insights and Forecast 2022-2032, USD Million
- Liquids- Market Insights and Forecast 2022-2032, USD Million
- Injectables- Market Insights and Forecast 2022-2032, USD Million
- Gels/Creams- Market Insights and Forecast 2022-2032, USD Million
- Patches- Market Insights and Forecast 2022-2032, USD Million
- By End User
- Hospitals- Market Insights and Forecast 2022-2032, USD Million
- Clinics/ASCs- Market Insights and Forecast 2022-2032, USD Million
- Homecare- Market Insights and Forecast 2022-2032, USD Million
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Product
- Market Size & Growth Outlook
- Thailand Systemic Analgesics Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Thailand Topical Analgesics/Anaesthetic Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Competitive Outlook
- Company Profiles
- Thai Nakorn Patana Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Taisho Pharmaceutical Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- GSK Consumer Healthcare
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Johnson & Johnson (Thailand) Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Haw Par Tiger Balm (Thailand) Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Golden Cup Pharmaceutical Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Pfizer (Thailand) Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Government Pharmaceutical Organization The
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Bertram Chemical (1982) Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Bristol-Myers Squibb (Thailand) Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Thai Nakorn Patana Co Ltd
- Company Profiles
- Disclaimer
| Segment | Sub-Segment |
|---|---|
| By Product |
|
| By Drug Type |
|
| By Route of Administration |
|
| By Pain Type |
|
| By Application |
|
| By Sales Channel |
|
| By Prescription Type |
|
| By Formulation |
|
| By End User |
|
Research Methodology
This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.
Secondary Research
The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.
Sources consulted during this phase included:
- Company annual reports, investor presentations, and press releases
- Industry white papers and certified publications
- Trade directories and market-recognized databases
- Articles from authoritative authors and reputable journals
- Gold and silver standard websites
Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.
Other key sources:
- Financial disclosures
- Industry associations and trade bodies
- News outlets and business magazines
- Academic journals and research studies
- Paid industry databases
Primary Research
To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.
On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.
On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.
Primary interviews provided critical inputs such as:
- Market size and revenue data
- Product and service breakdowns
- Market forecasts
- Regional and application-specific trends
Stakeholders consulted included:
- Leading OEM and solution providers
- Channel and distribution partners
- End users across various applications
- Independent consultants and industry specialists
Market Size Estimation and Data Triangulation
- Identifying Key Market Participants (Secondary Research)
- Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
- Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
- Extracting Earnings of Key Market Participants
- Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
- Methods: Earnings data can be gathered from:
- Publicly available financial reports (for listed companies).
- Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
- Annual reports and investor presentations of key players.
- Data Collation and Development of a Relevant Data Model
- Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
- Key KPIs: These could include:
- Market size, growth rate, and demand drivers.
- Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
- External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
- Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
- Scenario Analysis
- Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
- Types of Scenarios:
- Base Case: Based on current assumptions and historical data.
- Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
- Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.











